Nd:YAG laser iridotomy in the management of secondary glaucoma associated with Behçet's disease

European Journal of Ophthalmology

Volumn 17, Issue 2, 2007, Pages 191-195

  Elgin, Ufuk ^a,b   Berker, N ^a   Batman, A ^a   Soykan, E ^a  

^a Ankara Ulucanlar Eye Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et's disease; Nd:YAG laser iridotomy; Secondary glaucoma; Uveitis

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; AZATHIOPRINE; BRIMONIDINE; CYCLOSPORIN A; DORZOLAMIDE; FLUOROMETHOLONE; MITOMYCIN C; PREDNISOLONE; TIMOLOL MALEATE;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLOSED ANGLE GLAUCOMA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE SURGERY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; IRIDOTOMY; MALE; PHACOEMULSIFICATION; PRIORITY JOURNAL; TECHNIQUE; TRABECULECTOMY; UVEITIS; VISUAL ACUITY; YAG LASER;

EID: 34250359918     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700207     Document Type: Article

References (15)

1. Behçet H. Über rezidivierende aphtöse, durchein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologischen Wochenschrift Hamburg 1937; 105: 1152-63.
2. Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K. Epidemiological features and visual prognosis of Behçet's disease. Jpn J Ophthalmol 1999; 43: 312-7.
3. Atmaca LS, Idil A, Batioglu F. A descriptive study on Behçet's disease. Acta Ophthalmol Scand 1996; 74: 403-6.
4. Ben Ezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 1986; 70: 589-92.
5. Elgin U, Berker N, Batman A. Incidence of secondary glaucoma in Behçet's disease. J Glaucoma 2004; 13: 441-4.
6. Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA. Glaucoma associated with uveitis. Surv Ophthalmol 1997; 41: 361-94.
7. Merayo-Lloves J, Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999; 213: 300-4.
8. Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 2002; 46: 556-62.
9. Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002; 11: 189-96.
10. Yalvac IS, Sungur G, Turhan E, Eksioglu U, Duman S. Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Beḩet's disease. J Glaucoma 2004; 13: 450-3.
11. Ceballos EM, Parrish RK, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 2002; 109: 2256-60.
12. Spencer NA, Hall AJ, Stawell RJ. Nd:YAG laser iridotomy in uveitic glaucoma. Clin Exp Ophthalmol 2001; 29: 217-9.
13. Fleck BW, Dhillon B, Khanna V, Fairley E, McGlynn C. A randomized, prospective comparison of Nd:YAG laser iridotomy and operative peripheral iridectomy in fellow eyes. Eye 1991; 5: 315-21.
14. Hsiao CH, Hsu CT, Shen SC, Chen HS. Mid-term follow-up of Nd:YAG laser iridotomy in Asian eyes. Ophthalmic Surg Lasers Imaging 2003; 34: 291-8.
15. Del Priore LV, Robin AL, Pollack IP. Neodymium:YAG and argon laser iridotomy: long-term follow-up in a prospective randomized clinical trial. Ophthalmology 1988; 95: 1207-11.